Pulmonary Emphysema Subtypes on Computed Tomography: The MESA COPD Study - 31/12/13
Abstract |
Background |
Pulmonary emphysema is divided into 3 major subtypes at autopsy: centrilobular, paraseptal, and panlobular emphysema. These subtypes can be defined by visual assessment on computed tomography (CT); however, clinical characteristics of emphysema subtypes on CT are not well defined. We developed a reliable approach to visual assessment of emphysema subtypes on CT and examined if emphysema subtypes have distinct characteristics.
Methods |
The Multi-Ethnic Study of Atherosclerosis COPD Study recruited smokers with chronic obstructive pulmonary disease (COPD) and controls ages 50-79 years with ≥10 pack-years. Participants underwent CT following a standardized protocol. Definitions of centrilobular, paraseptal, and panlobular emphysema were obtained by literature review. Six-minute walk distance and pulmonary function were performed following guidelines.
Results |
Twenty-seven percent of 318 smokers had emphysema on CT. Interrater reliability of emphysema subtype was substantial (K: 0.70). Compared with participants without emphysema, individuals with centrilobular or panlobular emphysema had greater dyspnea, reduced walk distance, greater hyperinflation, and lower diffusing capacity. In contrast, individuals with paraseptal emphysema were similar to controls, except for male predominance. Centrilobular, but not panlobular or paraseptal, emphysema was associated with greater smoking history (+21 pack-years P <.001). Panlobular, but not other types of emphysema, was associated with reduced body mass index (−5 kg/m2; P = .01). Other than for dyspnea, these findings were independent of the forced expiratory volume in 1 second. Seventeen percent of smokers without COPD on spirometry had emphysema, which was independently associated with reduced walk distance.
Conclusions |
Emphysema subtypes on CT are common in smokers with and without COPD. Centrilobular and panlobular emphysema, but not paraseptal emphysema, have considerable symptomatic and physiological consequences.
Le texte complet de cet article est disponible en PDF.Keywords : Centrilobular, Computed tomography, Emphysema, Panlobular, Paraseptal
Plan
Funding: National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) R01-HL093081, R01-HL077612, R01-HL075476, and N01-HC95159-HC95169; Fonds de la recherche en santé Québec. |
|
Conflict of Interest: RGB holds grants from the National Institutes of Health (NIH), US Environmental Protection Agency, and Alpha-1 Foundation. EAH is a founder and shareholder of VIDA diagnostics, whose software was used in secondary analyses of this paper, and holds grants from NIH, Alpha-1 Foundation, and the American Lung Association. JDN holds grants from NIH and Siemens Healthcare, and is a paid consultant with patent pending for VIDA diagnostics. BMS receives funding from the Fonds de la recherche en santé Québec. For the remaining authors, no potential conflicts were declared. |
|
Authorship: All authors had access to the data and a role in writing the manuscript. |
Vol 127 - N° 1
P. 94.e7-94.e23 - janvier 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?